Consensus guidelines for the safe prescription and administration of oral bowel-cleansing agents

Gut

Volumn 61, Issue 11, 2012, Pages 1525-1532

  Connor, Andrew ^a   Tolan, Damian ^b   Hughes, Stephen ^c   Carr, Nick ^d   Tomson, Charles ^c  

^a DORSET COUNTY HOSPITAL   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c SOUTHMEAD HOSPITAL   (United Kingdom)

^d SINGLETON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CITRIC ACID; DIATRIZOATE; DIGESTIVE TRACT AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; GOLYTELY; INSULIN; MACROGOL; MAGNESIUM CARBONATE; MAGNESIUM CITRATE; MOVIPREP; NONSTEROID ANTIINFLAMMATORY AGENT; PICOSULFATE SODIUM; SENNA EXTRACT; SODIUM DIHYDROGEN PHOSPHATE;

ACUTE KIDNEY FAILURE; CEREBROVASCULAR DISEASE; COLONOSCOPY; CONGESTIVE HEART FAILURE; CONSENSUS; DIABETES MELLITUS; DIARRHEA; DRUG ADMINISTRATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; FAINTNESS; FLUID INTAKE; FLUID THERAPY; HEART MUSCLE ISCHEMIA; HEMATURIA; HEMODIALYSIS; HUMAN; HYPERMAGNESEMIA; HYPERNATREMIA; HYPERTENSION; HYPOCALCEMIA; HYPOKALEMIA; HYPONATREMIA; HYPOVOLEMIA; INTESTINE LAVAGE; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY GRAFT; LIVER CIRRHOSIS; NEPHROLITHIASIS; OUTCOME ASSESSMENT; PERIPHERAL VASCULAR DISEASE; PERITONEAL DIALYSIS; PHOSPHATE NEPHROPATHY; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROTEINURIA; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

ADMINISTRATION, ORAL; CATHARTICS; COLONOSCOPY; DRUG PRESCRIPTIONS; FEMALE; GREAT BRITAIN; HUMANS; INTESTINES; MALE; PHOSPHATES; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; SAFETY MANAGEMENT; THERAPEUTIC IRRIGATION;

EID: 84866895838     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2011-300861     Document Type: Review

References (61)

1. http://www.npsa.nhs.uk/nrls/alerts-and-directives/rapidrr/ reducing-risk-of-harm-from- oral-bowel-cleansing-solutions (accessed May 2009).
2. Wexner SD, Beck DE, Baron TH, et al; American Society of colon and Rectal Surgeons; American Society for gastrointestinal Endoscopy; Society of American gastrointestinal and endoscopic Surgeons. A consensus document on bowel preparation before colonoscopy: prepared by a task force from the American Society of Colon and Rectal Surgeons (ASCRS), the American Society for gastrointestinal Endoscopy (ASGE), and the Society of American gastrointestinal and Endoscopic Surgeons (SAGES). Gastrointest Endosc 2006;63 :894-909.
3. Guyatt GH, Oxman AD, Kunz R, et al. Going from evidence to recommendations. BMJ 2008;336:1049-51.
4. Jaeschke R, Guyatt GH, Dellinger P, et al. Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive. BMJ 2008;337:a744.
5. British National Formulary, London: BMJ Publishing Group Ltd and Royal Pharmaceutical Society of Great Britain, 2009.
6. El Sayed AM, Kanafani ZA, Mourad FH, et al. A randomized single-blind trial of whole versus split-dose polyethylene glycol-electrolyte solution for colonoscopy preparation. Gastrointest Endosc 2003;58:36-40.
7. Schiller LR. Clinical pharmacology and use of laxatives and lavage solutions. J Clin Gastroenterol 1999; 28:11-18.
8. Vanner SJ, MacDonald PH, Paterson WG, et al. A randomized prospective trial comparing oral sodium phosphate with standard polyethylene glycol-based lavage solution (Golytely) in the preparation of patients for colonoscopy. Am J Gastroenterol 1990;85:422-7.
9. Hsu CW, Imperiale TF. Meta-analysis and cost comparison of polyethylene glycol lavage versus sodium phosphate for colonoscopy preparation. Gastrointest Endosc 1998;48:276-82.
10. Cohen SM, Wexner SD, Binderow SR, et al . Prospective, randomized, endoscopicblinded trial comparing precolonoscopy bowel cleansing methods. Dis Colon Rectum 1994;37:689-96.
11. Frommer D. Cleansing ability and tolerance of three bowel preparations for colonoscopy. Dis Colon Rectum 1997;40 :100-4.
12. Kolts BE, Lyles WE, Achem SR, et al. A comparison of the effectiveness and patient tolerance of oral sodium phosphate, castor oil, and standard electrolyte lavage for colonoscopy or sigmoidoscopy preparation. Am J Gastroenterol 1993;88:1218-23.
13. Belsey J, Crosta C, Epstein O, et al. Meta-analysis: the relative efficacy of oral bowel preparations for colonoscopy 1985-2010. Aliment Pharmacol Ther 2012;35:222-37.
14. Nelson DB, Barkun AN, Block KP, et al. Technology status evaluation report. Colonoscopy preparations. Gastrointest Endosc 2001;54 :829-32.
15. Hoy SM, Scott LJ, Wagstaff AJ. Sodium picosulfate/magnesium citrate: a review of its use as a colorectal cleanser. Drugs 2009; 69:123-36.
16. Miki P Jr, Lemos CR, Popoutchi P, et al. Comparison of colon-cleansing methods in preparation for colonoscopy ecomparative efficacy of solutions of mannitol, sodium picosulfate and monobasic and dibasic sodium phosphates. Acta Cir Bras 2008;23 (Suppl 1):108-11.
17. Renaut AJ, Raniga S, Frizelle FA, et al. A randomized controlled trial comparing the efficacy and acceptability of phospo-soda buffered saline (Fleet) with sodium picosulphate/magnesium citrate (Picoprep) in the preparation of patients for colonoscopy. Colorectal Dis 2008;10:503-5.
18. Tjandra JJ, Chan M, Tagkalidis PP. Oral sodium phosphate (Fleet) is a superior colonoscopy preparation to Picoprep (sodium picosulfate-based preparation). Dis Colon Rectum 2006;49:616-20.
19. Schmidt LM, Williams P, King D, et al. Picoprep-3 is a superior colonoscopy preparation to Fleet: a randomized, controlled trial comparing the two bowel preparations. Dis Colon Rectum 2004; 47:238-42.
20. Yoshioka K, Connolly AB, Ogunbiyi OA, et al. Randomized trial of oral sodium phosphate compared with oral sodium picosulphate (Picolax) for elective colorectal surgery and colonoscopy. Dig Surg 2000;17:66-70.
21. Hamilton D, Mulcahy D, Walsh D, et al. Sodium picosulphate compared with polyethylene glycol solution for large bowel lavage: a prospective randomised trial. Br J Clin Pract 1996;50:73-5.
22. Macleod AJ, Duncan KA, Pearson RH, et al. A comparison of fleet Phospho-soda with Picolax in the preparation of the colon for double contrast barium enema. Clin Radiol 1998;53:612-14.
23. Taylor SA, Halligan S, Goh V, et al. Optimizing bowel preparation for multidetector row CT colonography: effect of Citramag and Picolax. Clin Radiol 2003;58:723-32.
24. Lai AK, Kwok PC, Man SW, et al. A blinded clinical trial comparing conventional cleansing enema, Pico-salax and Golytely for barium enema bowel preparation. Clin Radiol 1996;51:566-9.
25. Swarbrick MJ, Collins MC, Moore DJ, et al . A comparative trial of magnesium citrate (Citramag) and Picolax for barium enema bowel preparation. Clin Radiol 1994;49:379-81.
26. Mc Laughlin P, Eustace J, Mc Sweeney S, et al. Bowel preparation in CT colonography: electrolyte and renal function disturbances in the frail and elderly patient. Eur Radiol 2010;20:604-12.
27. Bowles CJ, Leicester R, Romaya C, et al. A prospective study of colonoscopy practice in the UK today: are we adequately prepared for national colorectal cancer screening tomorrow? Gut 2004;53:277-83.
28. Vradelis S, Kalaitzakis E, Sharifi Y, et al. Addition of senna improves quality of colonoscopy preparation with magnesium citrate. World J Gastroenterol 2009;15:1759-63.
29. Kastenberg D, Chasen R, Choudhary C, et al. Efficacy and safety of sodium phosphate tablets compared with PEG solution in colon cleansing: two identically designed, randomized, controlled, parallel group multicenter phase III trials. Gastrointest Endosc 2001;54:705-13.
30. Eschinger EJ, Littman JJ, Meyer K, et al. Safety of sodium phosphate tablets in patients receiving propofol-based sedation for colonoscopy. J Clin Gastroenterol 2004;38:425-8.
31. Reddy DN, Rao GV, Sriram PV. Efficacy and safety of oral sodium phosphate versus polyethylene glycol solution for bowel preparation for colonoscopy. Indian J Gastroenterol 2002;21:219-21.
32. Brunelli SM, Feldman HI, Latif SM, et al. A comparison of sodium phosphosoda purgative to polyethylene glycol bowel preparations prior to colonoscopy. Fam Med 2009;41:39-45.
33. Beloosesky Y, Grinblat J, Weiss A, et al. Electrolyte disorders following oral sodium phosphate administration for bowel cleansing in elderly patients. Arch Intern Med 2003;163:803-8.
34. Ainley EJ, Winwood PJ, Begley JP. Measurement of serum electrolytes and phosphate after sodium phosphate colonoscopy bowel preparation: an evaluation. Dig Dis Sci 2005;50:1319-23.
35. Ho JM, Juurlink DN, Cavalcanti RB. Hypokalemia following polyethylene glycol-based bowel preparation for colonoscopy in older hospitalized patients with significant comorbidities. Ann Pharmacother 2010;44:466-70.
36. Lien YH. Is bowel preparation before colonoscopy a risky business for the kidney? Nat Clin Pract Nephrol 2008;4:606-14.
37. Tjandra JJ, Tagkalidis P. Carbohydrate-electrolyte (E-Lyte) solution enhances bowel preparation with oral fleet phospho-soda. Dis Colon Rectum 2004;47:1181-6.
38. Frizelle FA, Colls BM. Hyponatremia and seizures after bowel preparation: report of three cases. Dis Colon Rectum 2005;48:393-6.
39. Nagler J, Poppers D, Turetz M. Severe hyponatremia and seizure following a polyethylene glycol-based bowel preparation for colonoscopy. J Clin Gastroenterol 2006;40:558-9.
40. Nyberg C, Hendel J, Nielsen OH. The safety of osmotically acting cathartics in colonic cleansing. Nat Rev Gastroenterol Hepatol 2010;7:557-64.
41. Markowitz GS, Radhakrishnan J, D'Agati VD. Towards the incidence of acute phosphate nephropathy. J Am Soc Nephrol 2007;18:3020-2.
42. Markowitz GS, Stokes MB, Radhakrishnan J, et al. Acute phosphate nephropathy following oral sodium phosphate bowel purgative: an underrecognized cause of chronic renal failure. J Am Soc Nephrol 2005;16:3389-96.
43. Gumurdulu Y, Serin E, Ozer B, et al . Age as a predictor of hyperphosphataemia after oral phosphosoda administration for colon preparation. J Gastroenterol Hepatol 2004;19:68-72.
44. Hookey LC, Vanner S. Recognizing the clinical contraindications to the use of oral sodium phosphate for colon cleansing: a case study. Can J Gastroenterol 2004;18:455-8.
45. Brunelli SM, Lewis JD, Gupta M, et al. Risk of kidney injury following oral phosphosoda bowel preparations. J Am Soc Nephrol 2007;18:3199-205.
46. Sica DA, Carl D, Zfass AM. Acute phosphate nephropathydan emerging issue. Am J Gastroenterol 2007;102:1844-7.
47. Food and Drug Administration. Oral Sodium Phosphate (OSP) Products for Bowel Cleansing. 2006. http://www.fda.gov/cder/drug/infopage/osp-solution (accessed 11 May 2009).
48. Kontani M, Hara A, Ohta S, et al. Hypermagnesemia induced by massive cathartic ingestion in an elderly woman without pre-existing renal dysfunction. Intern Med 2005;44:448-52.
49. Onishi S, Yoshino S. Cathartic-induced fatal hypermagnesemia in the elderly. Intern Med 2006;45 :207-10.
50. Schelling JR. Fatal hypermagnesemia. Clin Nephrol 2000;53:61-5.
51. Jung B, Påhlman L, Nyström PO; Mechanical Bowel Preparation Study Group. Multicentre randomized clinical trial of mechanical bowel preparation in elective colonic resection. Br J Surg 2007;94 :689-95.
52. Contant CM, Hop WC, van't Sant HP, et al. Mechanical bowel preparation for elective colorectal surgery: a multicentre randomised trial. Lancet 2007;370:2112-17.
53. Rex DK. Dosing considerations in the use of sodium phosphate bowel preparations for colonoscopy. Ann Pharmacother 2007;41:1466-75.
54. Rostom A, Jolicoeur E, Dubé C, et al. A randomized prospective trial comparing different regimens of oral sodium phosphate and polyethylene glycol-based lavage solution in the preparation of patients for colonoscopy. Gastrointest Endosc 2006;64:544-52.
55. Powell-Tuck J, Gosling P, Lobo DN, et al. British Consensus Guidelines on Intravenous Fluid Therapy for Adult Surgical Patients. GIFTASUP. http://www.renal. org/pages/media/Guidelines/GIFTASUP%20FINAL-31-10-08.pdf (accessed 10 Aug 2009).
56. Vilien M, Rytkønen M. Golytely preparation for colonoscopy: 1.5 liters is enough for outpatients. Endoscopy 1990;22 :168-70.
57. Barclay RL, Depew WT, Vanner SJ. Carbohydrate-electrolyte rehydration protects against intravascular volume contraction during colonic cleansing with orally administered sodium phosphate. Gastrointest Endosc 2002;56:633-8.
58. Beyea A, Block C, Schned A. Acute phosphate nephropathy following oral sodium phosphate solution to cleanse the bowel for colonoscopy. Am J Kidney Dis 2007;50:151-4.
59. Russmann S, Lamerato L, Marfatia A, et al. Risk of impaired renal function after colonoscopy: a cohort study in patients receiving either oral sodium phosphate or polyethylene glycol. Am J Gastroenterol 2007;102 :2655-63.
60. Singal AK, Rosman AS, Post JB, et al. The renal safety of bowel preparations for colonoscopy: a comparative study of oral sodium phosphate solution and polyethylene glycol. Aliment Pharmacol Ther 2008;27:41-7.
61. Hurst FP, Bohen EM, Osgard EM, et al. Association of oral sodium phosphate purgative use with acute kidney injury. J Am Soc Nephrol 2007;18:3192-8.